Early Childhood Neurodevelopmental Outcomes After Early Infant Invasive Group B Streptococcal Infection in Uganda - Scorecard - MDSpire

Early Childhood Neurodevelopmental Outcomes After Early Infant Invasive Group B Streptococcal Infection in Uganda

  • By

  • Samantha Sadoo

  • Carol Nanyunja

  • Mary Kyohere

  • Hannah G Davies

  • Valerie Tusubira

  • Cleophas Komugisha

  • Joseph Peacock

  • Margaret Sewegaba

  • Philippa Musoke

  • Musa Sekikubo

  • Kirsty Le Doare

  • Cally J Tann

  • PROGRESS Study Author Group

  • Abdelmajid Djennad

  • Agnes Nyamaizi

  • Agnes Ssali

  • Alexander Amone

  • Amusa Wamawobe

  • Annettee Nakimuli

  • Caitlin Farley

  • Carol Nanyunja

  • Christine Najuka

  • Cleophas Komugisha

  • Dan R Shelley

  • Edward A R Portal

  • Ellie Duckworth

  • Emilie Karafillakis

  • Geraldine O’Hara

  • Godfrey Matovu

  • Hannah G Davies

  • Janet Seeley

  • Joseph Peacock

  • Juliet Nsimire Sendagala

  • Katie Cowie

  • Kirsty Le Doare

  • Konstantinos Karampatsas

  • Lauren Hookham

  • Madeleine Cochet

  • Margaret Sewegaba

  • Mary Kyohere

  • Maxensia Owor

  • Melanie Etti

  • Merryn Voysey

  • Moses Musooko

  • Musa Sekikubo

  • Owen B Spiller

  • Patience Atuhaire

  • Paul T Heath

  • Philippa Musoke

  • Phiona Nalubega

  • Pooja Ravji

  • Richard Katungye

  • Ritah Namugumya

  • Rosalin Parks

  • Rose Azuba

  • Sam Kipyeko

  • Simon Beach

  • Stephen Bentley

  • Tim Old

  • Tobius Mutabazi

  • Valerie Tusubira

  • Vicki Chalker

  • March 10, 2025

  • 0 min

Share

Clinical Scorecard: Neurodevelopmental and Growth Outcomes at Two Years in Ugandan Infants Following Invasive Group B Streptococcal Sepsis

At a Glance

CategoryDetail
ConditionInvasive Group B Streptococcal (GBS) sepsis in infants under 3 months
Key MechanismsGBS infection causes sepsis and meningitis leading to neurodevelopmental impairment and growth deficits
Target PopulationInfants <3 months old in Uganda with culture-proven invasive GBS sepsis
Care SettingHospitals in Kampala, Uganda; follow-up in community and clinical settings

Key Highlights

  • 31% of GBS sepsis survivors had moderate to severe neurodevelopmental impairment versus 8.5% in non-GBS infants.
  • GBS sepsis survivors showed lower cognitive and language scores at 24 months corrected age.
  • GBS survivors had higher rates of undernutrition, especially those with cerebral palsy.

Guideline-Based Recommendations

Diagnosis

  • Culture-proven diagnosis of invasive GBS sepsis in infants <3 months presenting with signs of infection.

Management

  • Early identification and treatment of GBS sepsis in neonates and young infants.
  • No current prophylaxis for late-onset GBS disease; intrapartum antibiotics reduce early-onset disease.

Monitoring & Follow-up

  • Long-term neurodevelopmental follow-up up to at least 24 months corrected age for GBS sepsis survivors.
  • Use of standardized tools such as Bayley Scales of Infant Development and Hammersmith Infant Neurological Examination.
  • Growth monitoring including weight, height, mid-upper arm circumference, and head circumference.

Risks

  • High risk of cerebral palsy, global developmental delay, and undernutrition among GBS sepsis survivors.
  • Neurodevelopmental impairment impacts child functioning and family well-being, especially in low-resource settings.

Patient & Prescribing Data

Infants under 3 months with invasive GBS sepsis in a low-income Sub-Saharan African setting

Early antibiotic treatment critical; no prophylaxis for late-onset disease; survivors require long-term developmental support.

Clinical Best Practices

  • Include GBS sepsis survivors in structured long-term follow-up programs for neurodevelopmental and growth assessment.
  • Initiate early referrals to support services for children with neurodevelopmental impairment.
  • Address nutritional needs, particularly in children with cerebral palsy post-GBS sepsis.
  • Utilize gestational age matching and standardized neurodevelopmental assessments for accurate outcome evaluation.

References

Original Source(s)

Early Childhood Neurodevelopmental Outcomes After Early Infant Invasive Group B Streptococcal Infection in Uganda

  • by Samantha Sadoo, Carol Nanyunja, Mary Kyohere, Hannah G Davies, Valerie Tusubira, Cleophas Komugisha, Joseph Peacock, Margaret Sewegaba, Philippa Musoke, Musa Sekikubo, Kirsty Le Doare, Cally J Tann, PROGRESS Study Author Group, Abdelmajid Djennad, Agnes Nyamaizi, Agnes Ssali, Alexander Amone, Amusa Wamawobe, Annettee Nakimuli, Caitlin Farley, Carol Nanyunja, Christine Najuka, Cleophas Komugisha, Dan R Shelley, Edward A R Portal, Ellie Duckworth, Emilie Karafillakis, Geraldine O’Hara, Godfrey Matovu, Hannah G Davies, Janet Seeley, Joseph Peacock, Juliet Nsimire Sendagala, Katie Cowie, Kirsty Le Doare, Konstantinos Karampatsas, Lauren Hookham, Madeleine Cochet, Margaret Sewegaba, Mary Kyohere, Maxensia Owor, Melanie Etti, Merryn Voysey, Moses Musooko, Musa Sekikubo, Owen B Spiller, Patience Atuhaire, Paul T Heath, Philippa Musoke, Phiona Nalubega, Pooja Ravji, Richard Katungye, Ritah Namugumya, Rosalin Parks, Rose Azuba, Sam Kipyeko, Simon Beach, Stephen Bentley, Tim Old, Tobius Mutabazi, Valerie Tusubira, Vicki Chalker

  • March 10, 2025

Related Content

Pharmacological intervention of the HMGB1-pCTS-L axis to ameliorate inflammatory diseases

Diagnostic performance of interleukin-27 and C-reactive protein in neonatal sepsis: an updated systematic review and meta-analysis

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study